Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1982 1
1984 1
2011 1
2016 1
2017 2
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
[Pharmacotherapy of attention deficit hyperactivity disorder in children: the results of a multicenter double-blind placebo-controlled study of hopantenic acid].
Zavadenko NN, Suvorinova NY, Vakula IN, Malinina EV, Kuzenkova LM. Zavadenko NN, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(5):39-45. doi: 10.17116/jnevro20171175139-45. Zh Nevrol Psikhiatr Im S S Korsakova. 2017. PMID: 28638029 Clinical Trial. Russian.
AIM: To assess the efficacy and safety of hopantenic acid (pantogam) compared to placebo in the treatment of attention deficit hyperactivity disorder (ADHD) in children, aged from 6 to 12 years, during 4 month in the prospective multicenter comp …
AIM: To assess the efficacy and safety of hopantenic acid (pantogam) compared to placebo in the treatment of attention defi …
[Attention-deficit hyperactivity disorder: determination of the optimal medical treatment duration].
Zavadenko NN, Suvorinova NIu. Zavadenko NN, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2011;111(10 Pt 1):28-32. Zh Nevrol Psikhiatr Im S S Korsakova. 2011. PMID: 22500309 Russian.
Thirty-two patients with attention-deficit hyperactivity disorder (ADHD), 23 boys and 9 girls, aged 6-12 years, were examined in two months intervals during the long-term treatment (up to 6-8 months) with pantogam (homopantothenic acid) in daily …
Thirty-two patients with attention-deficit hyperactivity disorder (ADHD), 23 boys and 9 girls, aged 6-12 years, …
Independent and joint association of cord plasma pantothenate and cysteine levels with autism spectrum disorders and other neurodevelopmental disabilities in children born term and preterm.
Raghavan R, Wang G, Hong X, Pearson C, Xie H, Adams WG, Augustyn M, Wang X. Raghavan R, et al. Precis Nutr. 2023 May 11;2(2):e00036. doi: 10.1097/PN9.0000000000000036. eCollection 2023 Jun. Precis Nutr. 2023. PMID: 37745027 Free PMC article.
BACKGROUND: Pantothenate (vitamin B5) is a precursor for coenzyme A (CoA) synthesis, which serves as a cofactor for hundreds of metabolic reactions. Cysteine is an amino acid in the CoA synthesis pathway. To date, research on the combined role of early life pantothenate an …
BACKGROUND: Pantothenate (vitamin B5) is a precursor for coenzyme A (CoA) synthesis, which serves as a cofactor for hundreds of metabolic re …
[Influence of pantogam and atomoxetine on attention stability and distribution of dopamine D2 and GABAB receptors in the attention deficit mouse model].
Kovalev GI, Sukhorukova NA, Vasileva EV, Kondrakhin EA, Salimov RM. Kovalev GI, et al. Biomed Khim. 2021 Sep;67(5):402-410. doi: 10.18097/PBMC20216705402. Biomed Khim. 2021. PMID: 34730553 Russian.
The closed enriched cross maze test was employed as a new experimental model of the attention deficit disorder (ADD) for evaluation of the behavioral and neurochemical effects of the nootropic drug pantogam (100 mg/kg, intraperitoneally) and atomoxetine hydro …
The closed enriched cross maze test was employed as a new experimental model of the attention deficit disorder (ADD) fo …
Effects of megavitamin therapy on children with attention deficit disorders.
Haslam RH, Dalby JT, Rademaker AW. Haslam RH, et al. Pediatrics. 1984 Jul;74(1):103-11. Pediatrics. 1984. PMID: 6234505 Clinical Trial.
The effectiveness of a megavitamin regimen utilizing a two-stage trial in 41 subjects with attention deficit disorders was studied. Stage 1 was a 3-month clinical trial of vitamins (daily maximum: 3 g of niacinamide and ascorbic acid, 1.2 g of calcium pantoth …
The effectiveness of a megavitamin regimen utilizing a two-stage trial in 41 subjects with attention deficit disorders was stu …
[Pantogam augmentation in hyperkinetic behavior disorder treatment].
Kupriyanova TA, Koren EV. Kupriyanova TA, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2016;116(6):66-69. doi: 10.17116/jnevro20161166166-69. Zh Nevrol Psikhiatr Im S S Korsakova. 2016. PMID: 27456906 Russian.
A clinical case of a child with hyperkinetic conduct disorder is presented, with symptoms of hyperkinetic disorder itself closely intertwining with symptoms of conduct disorder. ...The proposed strategy can contribute to improvement of treatment results for c …
A clinical case of a child with hyperkinetic conduct disorder is presented, with symptoms of hyperkinetic disorder itself clos …
[A strategy for increasing the efficiency of psychopharmacological treatment of hyperkinetic behavior disorder with pantogam].
Kupriyanova TA, Koren EV, Alabusheva NN. Kupriyanova TA, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(11. Vyp. 2):75-79. doi: 10.17116/jnevro201711711275-79. Zh Nevrol Psikhiatr Im S S Korsakova. 2017. PMID: 29359723 Clinical Trial. Russian.
AIM: To assess short-term efficiency of hopantenic acid (pantogam) in the treatment of children with hyperkinetic behavior disorder, in whom the previous treatment with atomoxetine was not efficient. ...The proposed therapeutic strategy can help to improve treatment …
AIM: To assess short-term efficiency of hopantenic acid (pantogam) in the treatment of children with hyperkinetic behavior disorde …